Transient normal platelet counts and decreased requirement for interferon during pregnancy in essential thrombocythaemia

Br J Haematol. 1996 Feb;92(2):491-3. doi: 10.1046/j.1365-2141.1996.d01-1476.x.

Abstract

We report on the remarkable decrease in the platelet counts during pregnancy in two women with essential thrombocythaemia following treatment with recombinant interferon-alpha (r-IFN-alpha). Prior to pregnancy, the first patient was treated for 10 months with r-IFN-alpha 3 x 10(6) units/d six times per week, and the platelet count ranged between 750 and 800 x 10(9)/l. Starting from the sixth week of gestation, the platelet count decreased to normal levels and remained so, resulting in a lower r-IFN-alpha requirement. Following successful delivery of a healthy newborn an abrupt rise of the platelet count to pre-gestation values was observed, necessitating increased r-IFN-alpha dosage before pregnancy. The second patient when she became pregnant had been treated with r-IFN-alpha 3 x 10(6) units/d six times per week for 10 weeks. Starting from the 24th week of gestation the platelet count decreased, and despite reduction in the dose of r-IFN-alpha reached normal values at the time of delivery. The exact mechanism for the platelet count normalization during pregnancy is unclear, and several possibilities are discussed.

Publication types

  • Case Reports

MeSH terms

  • Female
  • Humans
  • Interferon Type I / administration & dosage*
  • Interferon Type I / therapeutic use
  • Middle Aged
  • Platelet Count
  • Pregnancy
  • Pregnancy Complications, Hematologic / blood*
  • Pregnancy Complications, Hematologic / therapy
  • Recombinant Proteins
  • Thrombocythemia, Essential / blood*
  • Thrombocythemia, Essential / therapy

Substances

  • Interferon Type I
  • Recombinant Proteins